23 February 2018 The evolution of phase holographic imaging from a research idea to publicly traded company
Author Affiliations +
Proceedings Volume 10503, Quantitative Phase Imaging IV; 105030V (2018) https://doi.org/10.1117/12.2290078
Event: SPIE BiOS, 2018, San Francisco, California, United States
Recognizing the value and unmet need for label-free kinetic cell analysis, Phase Holograhic Imaging defines its market segment as automated, easy to use and affordable time-lapse cytometry. The process of developing new technology, meeting customer expectations, sources of corporate funding and R&D adjustments prompted by field experience will be reviewed. Additionally, it is discussed how relevant biological information can be extracted from a sequence of quantitative phase images, with negligible user assistance and parameter tweaking, to simultaneously provide cell culture characteristics such as cell growth rate, viability, division rate, mitosis duration, phagocytosis rate, migration, motility and cell-cell adherence without requiring any artificial cell manipulation.
Conference Presentation
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Peter Egelberg, Peter Egelberg, "The evolution of phase holographic imaging from a research idea to publicly traded company", Proc. SPIE 10503, Quantitative Phase Imaging IV, 105030V (23 February 2018); doi: 10.1117/12.2290078; https://doi.org/10.1117/12.2290078

Back to Top